The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum.
Open Access
- 1 May 1995
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 39 (5), 519-526
- https://doi.org/10.1111/j.1365-2125.1995.tb04489.x
Abstract
1. The major serum proteins which bind halofantrine were identified by size exclusion chromatography. In addition, the binding affinity of halofantrine to human erythrocytes and serum proteins was measured by an erythrocyte partitioning technique. The influence of serum-drug binding on the distribution of halofantrine in whole blood was estimated by simulating several disease-related changes in the levels of the most important binding proteins. 2. The chromatographic resolution of serum preincubated with halofantrine allowed a quantitative analysis of binding to low density lipoproteins, high density lipoproteins, alpha 1-acid glycoprotein and albumin using the erythrocyte partitioning technique. Very low density lipoproteins did not bind halofantrine to a significant extent. 3. In whole blood halofantrine is bound to serum proteins (83%) and to erythrocytes (17%). Low density lipoproteins (affinity constant nKP = 44.4 l g-1) and high density lipoproteins (nKP = 14.4 l g-1) were the most important binding proteins in serum. alpha 1-acid glycoprotein (nKP = 4.39 l g-1) and albumin (nKP = 0.27 l g-1) had relatively low binding affinities. 4. The concentration of serum proteins influences both the fraction of unbound drug and the fraction of drug associated with the erythrocytes. Changes in serum protein concentrations often encountered in malaria are likely to increase both the unbound fraction and the fraction bound to the erythrocytes.Keywords
This publication has 27 references indexed in Scilit:
- Clinical Pharmacokinetics of HalofantrineClinical Pharmacokinetics, 1994
- Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malariaBritish Journal of Clinical Pharmacology, 1993
- Cardiac effect of halofantrineThe Lancet, 1993
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993
- Serum protein concentrations in Plasmodium falciparum malariaActa Tropica, 1992
- Methods of Determining Plasma and Tissue Binding of DrugsClinical Pharmacokinetics, 1992
- Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytesBiochemical Pharmacology, 1990
- Multiple Binding of Bepridil in Human BloodPharmacology, 1984
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979